|Entries for the 2012
Medicines New Zealand Value of Medicines Award are now open.
“This $20,000 award aims to stimulate
research that improves the understanding, effectiveness or safety of
the use of medicines,” Medicines New Zealand General Manager Kevin
“The aim of the Medicines New
Zealand Value of Medicines Award is to encourage and showcase
innovative projects that have the potential to improve health
outcomes for New Zealanders, through the use of medicines.
“New Zealand’s research community
produces an exceptionally high standard of innovative work, which we
believe should be widely recognised and celebrated.
The work should have direct
relevance to the current or future provision of healthcare in New
“As the industry association
representing innovative pharmaceutical companies in New Zealand we
work to encourage the understanding that investing in modern
medicines is an important part of future proofing this country’s
productivity, enabling people to stay well with a better quality of
life for longer and thereby reducing the strain on other parts of
the healthcare system.
“Furthermore we believe the
acknowledgement of research in the area of scientific innovation,
supports the Government in its goal to attract and retain our
scientific talent,” Mr Sheehy says.
Medicines New Zealand encourages
any researcher or clinician whose work aims to demonstrate the value
of medicines to apply.
Entries close on 14 September 2012
and the winner will be announced on 9 October 2012.